The membrane expressions of E-cadherin and β-catenin complexes are often inversely correlated with tumor grade and survival stage in cancer patients, indicating favorable progression-free survival after anti-cancer therapy [8,26–30]. This evidence concerns the gene CDH1 and neoplasm.